Kimberly-Clark Reports Q3 Sales of $4.1 Billion, Adjusted EPS of $1.70

Kimberly-Clark reported Q3 2026 net sales of $4.1B, down 0.4% YoY, and adjusted EPS of $1.70. Gross profit was $1.44B with a 34.9% margin. The company completed its acquisition of Kenvue and reaffirmed its 2026 outlook, expecting mid-single-digit adjusted operating profit growth and high-single-digit adjusted EPS growth.

Original reporting
Published Nov 5, 2026, 11:43 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 11:47 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Kimberly-Clark Reports Q3 Sales of $4.1 Billion, Adjusted EPS of $1.70 — source image
Decision brief

The 30-second read

$KMBBearishHigh
01

Why it matters

The earnings release introduces new data on sales trends and EPS performance, shaping short‑term price action.

02

Market read

First‑report earnings for a major consumer staple; investors will reassess outlook and peer performance.

03

What to watch

International Personal Care disruption in China may be temporary; growth in South Korea and Indonesia could offset longer term.

Relevance 9/10Novelty 9/10Timing: after-hours release

Background

Kimberly-Clark released its Q3 2026 earnings via an 8‑K filing, providing the first public numbers for the quarter.

Company-level read

Ticker impact

$KMBBearishHigh confidence
Context

Q3 2026 net sales $4.1B (down 0.4% YoY) and adjusted EPS $1.70, reaffirming 2026 outlook.

Expected impact

likely downward pressure as market prices in the sales decline

Evidence & confidence

Revenue fell slightly while EPS rose modestly; investors often penalize revenue weakness in a large consumer staple.

Market effects

May signal softness in consumer staples demand, prompting peers to watch sales trends.

North America sales growth offsets inventory pressures, but international personal care faces China disruption.

Large‑cap consumer staple earnings can influence broader market sentiment on earnings season.

Counterpoint

Despite revenue dip, the EPS beat and integration of Kenvue could drive upside if cost synergies materialize.

Key entities

  • Kimberly-Clark Corp.

    Large‑cap consumer staples manufacturer reporting Q3 results.

Related articles

$KMBMedAI 8/10

Kimberly-Clark’s Dividend Is Up 392% Since 1999. Can Its $49 Billion Deal Put That at Risk?

Kimberly-Clark (KMB) has increased its dividend by 392% since 1999, with a current quarterly payout of $1.28. The company's $49 billion acquisition of Kenvue, funded partly by debt, may test its dividend streak. In 2025, free cash flow was $1.64 billion, slightly below the $1.66 billion paid in dividends. Management aims for reduced leverage and cost synergies to support earnings and the dividend.

$KMBMedAI 8/10

Kimberly-Clark backs 2026 outlook despite China disruptions

Kimberly-Clark reported Q3 2026 net sales of $4.13B, down 0.4% YoY, with adjusted EPS up 17.2% to $1.70. China disruptions and North American inventory movements impacted sales. The company reaffirmed its 2026 outlook, expecting mid-single-digit adjusted operating profit growth and high single-digit adjusted EPS growth.

$KMBMed

Kimberly-Clark Corp (KMB) (Q3 2026) Earnings Call Highlights: Kenvue Deal Closes

Kimberly-Clark (KMB) CEO Mike Hsu and CFO Nelson Urdaneta discussed Q3 2026 earnings, Kenvue integration, and 2027 outlook. Hsu highlighted Kenvue's 3% organic growth and progress in brand performance. Urdaneta cited cost-mitigating actions and easier Q4 comparisons. They addressed North America's share performance, diaper market dynamics, and synergy plans, including $1.9B in cost savings. KMB maintained fiscal 2026 guidance despite challenges.